Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Etrasimod by Pfizer for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Etrasimod is under clinical development by Pfizer and currently in Phase III for Crohn's Disease (Regional Enteritis). According to GlobalData,...
Data Insights
Etrasimod by Pfizer for Eosinophilic Esophagitis: Likelihood of Approval
Etrasimod is under clinical development by Pfizer and currently in Phase II for Eosinophilic Esophagitis. According to GlobalData, Phase II...